Skip to main content
Erschienen in: Cancer Causes & Control 10/2010

01.10.2010 | Original paper

Hormonal exposures and the risk of uveal melanoma

verfasst von: Thomas Behrens, Linda Kaerlev, Ian Cree, Jean-Michel Lutz, Noemia Afonso, Mikael Eriksson, Pascal Guénel, Franco Merletti, Maria Morales-Suarez-Varela, Aivars Stengrevics, Svend Sabroe, Diane Cyr, Agustin Llopis-González, Giuseppe Gorini, Galina Sharkova, Lennart Hardell, Wolfgang Ahrens

Erschienen in: Cancer Causes & Control | Ausgabe 10/2010

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Several studies suggest that hormonal mechanisms may be associated with the development of uveal melanoma. Therefore, the association between the risk of uveal melanoma and exposure to hormonal exposures was investigated in a case–control study from nine European countries.

Methods

Incident cases of uveal melanoma were frequency-matched to population and hospital controls by country, age, and sex. Female subjects were asked about their reproductive history, use of menopausal hormone replacement therapy and oral contraceptives. Among men, occupational handling of oils while working with transformers or capacitors which contain polychlorinated biphenyls (PCB) was solicited. Unconditional logistic regression analyses were calculated, adjusting for several potential confounders. Analyses were stratified by sex.

Results

Two hundred and ninety-three cases (165 men, 128 women) and 3,198 control subjects (2,121 men, 1,077 women) were interviewed. Among women, no associations were observed with hormonal status variables, intake of hormonal therapy or intake of oral contraceptives. Men showed an increased risk with occupational exposure to transformer/capacitor oils (OR = 2.74; Bonferroni-corrected 99.3% CI 1.07–7.02). However, these results were based on few exposed subjects only.

Conclusion

The results of this study do not support the hypothesis of a hormonal influence in the carcinogenesis of uveal melanoma. Our finding of a potentially increased risk with PCB-containing oils requires further research.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Stang A, Parkin DM, Ferlay J, Jöckel KH (2005) International uveal melanoma incidence trends in view of a decreasing proportion of morphological verification. Int J Cancer 114:114–123CrossRefPubMed Stang A, Parkin DM, Ferlay J, Jöckel KH (2005) International uveal melanoma incidence trends in view of a decreasing proportion of morphological verification. Int J Cancer 114:114–123CrossRefPubMed
2.
Zurück zum Zitat Kanter-Lewensohn L, Girnita L, Girnita A et al (2000) Tamoxifen-induced cell death in malignant melanoma cells: possible involvement of the insulin-like growth factor-1 (IGF-1) pathway. Mol Cell Endocrinol 165:131–137CrossRefPubMed Kanter-Lewensohn L, Girnita L, Girnita A et al (2000) Tamoxifen-induced cell death in malignant melanoma cells: possible involvement of the insulin-like growth factor-1 (IGF-1) pathway. Mol Cell Endocrinol 165:131–137CrossRefPubMed
3.
Zurück zum Zitat Roberts JE, Wiechmann AF, Hu DN (2000) Melatonin receptors in human uveal melanocytes and melanoma cells. J Pineal Res 28:165–171CrossRefPubMed Roberts JE, Wiechmann AF, Hu DN (2000) Melatonin receptors in human uveal melanocytes and melanoma cells. J Pineal Res 28:165–171CrossRefPubMed
4.
Zurück zum Zitat Hemminki K, Jiang Y (2001) Association of ocular melanoma with breast cancer but not with cutaneous melanoma: results from the Swedish Family-Cancer Database. Int J Cancer 94:907–909CrossRefPubMed Hemminki K, Jiang Y (2001) Association of ocular melanoma with breast cancer but not with cutaneous melanoma: results from the Swedish Family-Cancer Database. Int J Cancer 94:907–909CrossRefPubMed
5.
Zurück zum Zitat Lea CS, Holly EA, Hartge P et al (2007) Reproductive risk factors for cutaneous melanoma in women: a case-control study. Am J Epidemiol 165:505–513CrossRefPubMed Lea CS, Holly EA, Hartge P et al (2007) Reproductive risk factors for cutaneous melanoma in women: a case-control study. Am J Epidemiol 165:505–513CrossRefPubMed
6.
Zurück zum Zitat Hartge P, Tucker MA, Shields JA, Augsburger J, Hoover RN, Fraumeni JF Jr (1989) Case-control study of female hormones and eye melanoma. Cancer Res 49:4622–4625PubMed Hartge P, Tucker MA, Shields JA, Augsburger J, Hoover RN, Fraumeni JF Jr (1989) Case-control study of female hormones and eye melanoma. Cancer Res 49:4622–4625PubMed
7.
Zurück zum Zitat Holly EA, Aston DA, Ahn DK, Kristiansen JJ, Char DH (1991) Uveal melanoma, hormonal and reproductive factors in women. Cancer Res 51(5):1370–1372PubMed Holly EA, Aston DA, Ahn DK, Kristiansen JJ, Char DH (1991) Uveal melanoma, hormonal and reproductive factors in women. Cancer Res 51(5):1370–1372PubMed
8.
Zurück zum Zitat Stevens RG, Davis S (1996) The melatonin hypothesis: electric power and breast cancer. Environ Health Perspect 104(Suppl 1):135–140CrossRefPubMed Stevens RG, Davis S (1996) The melatonin hypothesis: electric power and breast cancer. Environ Health Perspect 104(Suppl 1):135–140CrossRefPubMed
9.
Zurück zum Zitat Shah PN, Mhatre MC, Kothari LS (1984) Effect of melatonin on mammary carcinogenesis in intact and pinealectomized rats in varying photoperiods. Cancer Res 44(8):3403–3407PubMed Shah PN, Mhatre MC, Kothari LS (1984) Effect of melatonin on mammary carcinogenesis in intact and pinealectomized rats in varying photoperiods. Cancer Res 44(8):3403–3407PubMed
10.
Zurück zum Zitat Behrens T, Lynge E, Cree I et al (2010) Occupational exposure to electromagnetic fields and sex-differential risk of uveal melanoma. Occ Environ Med (in press) Behrens T, Lynge E, Cree I et al (2010) Occupational exposure to electromagnetic fields and sex-differential risk of uveal melanoma. Occ Environ Med (in press)
11.
Zurück zum Zitat Bosetti C, Negri E, Fattore E, La VC (2003) Occupational exposure to polychlorinated biphenyls and cancer risk. Eur J Cancer Prev 12:251–255CrossRefPubMed Bosetti C, Negri E, Fattore E, La VC (2003) Occupational exposure to polychlorinated biphenyls and cancer risk. Eur J Cancer Prev 12:251–255CrossRefPubMed
12.
Zurück zum Zitat Engel LS, Lan Q, Rothman N (2007) Polychlorinated biphenyls and non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 16:373–376CrossRefPubMed Engel LS, Lan Q, Rothman N (2007) Polychlorinated biphenyls and non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 16:373–376CrossRefPubMed
13.
Zurück zum Zitat Adenugba A, Khan SA, Taylor-Robinson SD et al (2009) Polychlorinated biphenyls in bile of patients with biliary tract cancer. Chemosphere 76:841–846CrossRefPubMed Adenugba A, Khan SA, Taylor-Robinson SD et al (2009) Polychlorinated biphenyls in bile of patients with biliary tract cancer. Chemosphere 76:841–846CrossRefPubMed
14.
Zurück zum Zitat Hardell L, Van BB, Lindstrom G et al (2003) Increased concentrations of polychlorinated biphenyls, hexachlorobenzene, and chlordanes in mothers of men with testicular cancer. Environ Health Perspect 111:930–934CrossRefPubMed Hardell L, Van BB, Lindstrom G et al (2003) Increased concentrations of polychlorinated biphenyls, hexachlorobenzene, and chlordanes in mothers of men with testicular cancer. Environ Health Perspect 111:930–934CrossRefPubMed
15.
Zurück zum Zitat Bahn AK, Rosenwaike I, Hermann N, Grover P, Stellman J, O’Leary K (1976) Letter: melanoma after exposure to PCB’s. N Engl J Med 295:450PubMed Bahn AK, Rosenwaike I, Hermann N, Grover P, Stellman J, O’Leary K (1976) Letter: melanoma after exposure to PCB’s. N Engl J Med 295:450PubMed
16.
Zurück zum Zitat Sinks T, Steele G, Smith AB, Watkins K, Shults RA (1992) Mortality among workers exposed to polychlorinated biphenyls. Am J Epidemiol 136:389–398PubMed Sinks T, Steele G, Smith AB, Watkins K, Shults RA (1992) Mortality among workers exposed to polychlorinated biphenyls. Am J Epidemiol 136:389–398PubMed
17.
Zurück zum Zitat Lynge E, Afonso N, Kaerlev L et al (2005) European multi-centre case-control study on risk factors for rare cancers of unknown aetiology. Eur J Cancer 41:601–612CrossRefPubMed Lynge E, Afonso N, Kaerlev L et al (2005) European multi-centre case-control study on risk factors for rare cancers of unknown aetiology. Eur J Cancer 41:601–612CrossRefPubMed
18.
Zurück zum Zitat Njor SH, Pedersen AT, Schwartz W, Hallas J, Lynge E (2009) Minimizing misclassification of hormone users at mammography screening. Int J Cancer 124:2159–2165CrossRefPubMed Njor SH, Pedersen AT, Schwartz W, Hallas J, Lynge E (2009) Minimizing misclassification of hormone users at mammography screening. Int J Cancer 124:2159–2165CrossRefPubMed
19.
Zurück zum Zitat Gallagher RP, Elwood JM, Rootman J et al (1985) Risk factors for ocular melanoma: Western Canada Melanoma Study. J Natl Cancer Inst 74:775–778PubMed Gallagher RP, Elwood JM, Rootman J et al (1985) Risk factors for ocular melanoma: Western Canada Melanoma Study. J Natl Cancer Inst 74:775–778PubMed
20.
Zurück zum Zitat Egan KM, Quinn JL, Gragoudas ES (1999) Childbearing history associated with improved survival in choroidal melanoma. Arch Ophthalmol 117(7):939–942PubMed Egan KM, Quinn JL, Gragoudas ES (1999) Childbearing history associated with improved survival in choroidal melanoma. Arch Ophthalmol 117(7):939–942PubMed
21.
Zurück zum Zitat Bonefeld-Jorgensen EC, Andersen HR, Rasmussen TH, Vinggaard AM (2001) Effect of highly bioaccumulated polychlorinated biphenyl congeners on estrogen and androgen receptor activity. Toxicology 158:141–153CrossRefPubMed Bonefeld-Jorgensen EC, Andersen HR, Rasmussen TH, Vinggaard AM (2001) Effect of highly bioaccumulated polychlorinated biphenyl congeners on estrogen and androgen receptor activity. Toxicology 158:141–153CrossRefPubMed
22.
Zurück zum Zitat Ulbrich B, Stahlmann R (2004) Developmental toxicity of polychlorinated biphenyls (PCBs): a systematic review of experimental data. Arch Toxicol 78:252–268PubMed Ulbrich B, Stahlmann R (2004) Developmental toxicity of polychlorinated biphenyls (PCBs): a systematic review of experimental data. Arch Toxicol 78:252–268PubMed
23.
Zurück zum Zitat Andric NL, Kostic TS, Zoric SN, Stanic BD, Andric SA, Kovacevic RZ (2006) Effect of a PCB-based transformer oil on testicular steroidogenesis and xenobiotic-metabolizing enzymes. Reprod Toxicol 22(1):102–110CrossRefPubMed Andric NL, Kostic TS, Zoric SN, Stanic BD, Andric SA, Kovacevic RZ (2006) Effect of a PCB-based transformer oil on testicular steroidogenesis and xenobiotic-metabolizing enzymes. Reprod Toxicol 22(1):102–110CrossRefPubMed
24.
Zurück zum Zitat Ajani UA, Seddon JM, Hsieh CC, Egan KM, Albert DM, Gragoudas ES (1992) Occupation and risk of uveal melanoma. An exploratory study. Cancer 70:2891–2900CrossRefPubMed Ajani UA, Seddon JM, Hsieh CC, Egan KM, Albert DM, Gragoudas ES (1992) Occupation and risk of uveal melanoma. An exploratory study. Cancer 70:2891–2900CrossRefPubMed
25.
Zurück zum Zitat Liljegren G, Hardell L, Lindstrom G, Dahl P, Magnuson A (1998) Case-control study on breast cancer and adipose tissue concentrations of congener specific polychlorinated biphenyls, DDE and hexachlorobenzene. Eur J Cancer Prev 7:135–140PubMed Liljegren G, Hardell L, Lindstrom G, Dahl P, Magnuson A (1998) Case-control study on breast cancer and adipose tissue concentrations of congener specific polychlorinated biphenyls, DDE and hexachlorobenzene. Eur J Cancer Prev 7:135–140PubMed
26.
Zurück zum Zitat Silver SR, Whelan EA, Deddens JA et al (2009) Occupational exposure to polychlorinated biphenyls and risk of breast cancer. Environ Health Perspect 117:276–282PubMed Silver SR, Whelan EA, Deddens JA et al (2009) Occupational exposure to polychlorinated biphenyls and risk of breast cancer. Environ Health Perspect 117:276–282PubMed
27.
Zurück zum Zitat McGlynn KA, Quraishi SM, Graubard BI, Weber JP, Rubertone MV, Erickson RL (2009) Polychlorinated biphenyls and risk of testicular germ cell tumors. Cancer Res 69:1901–1909CrossRefPubMed McGlynn KA, Quraishi SM, Graubard BI, Weber JP, Rubertone MV, Erickson RL (2009) Polychlorinated biphenyls and risk of testicular germ cell tumors. Cancer Res 69:1901–1909CrossRefPubMed
28.
Zurück zum Zitat Monarrez-Espino J, Stang A, Bromen K, Merzenich H, Anastassiou G, Jöckel KH (2002) Occupation as a risk factor for uveal melanoma in Germany. Scand J Work Environ Health 28:270–277PubMed Monarrez-Espino J, Stang A, Bromen K, Merzenich H, Anastassiou G, Jöckel KH (2002) Occupation as a risk factor for uveal melanoma in Germany. Scand J Work Environ Health 28:270–277PubMed
29.
Zurück zum Zitat Fortes C, de Vries E (2008) Nonsolar occupational risk factors for cutaneous melanoma. Int J Dermatol 47:319–328CrossRefPubMed Fortes C, de Vries E (2008) Nonsolar occupational risk factors for cutaneous melanoma. Int J Dermatol 47:319–328CrossRefPubMed
30.
Zurück zum Zitat Hakulinen T, Teppo L, Saxen E (1978) Cancer of the eye, a review of trends and differentials. World Health Stat Q 31:143–158PubMed Hakulinen T, Teppo L, Saxen E (1978) Cancer of the eye, a review of trends and differentials. World Health Stat Q 31:143–158PubMed
31.
Zurück zum Zitat Shah CP, Weis E, Lajous M, Shields JA, Shields CL (2005) Intermittent and chronic ultraviolet light exposure and uveal melanoma: a meta-analysis. Ophthalmology 112:1599–1607CrossRefPubMed Shah CP, Weis E, Lajous M, Shields JA, Shields CL (2005) Intermittent and chronic ultraviolet light exposure and uveal melanoma: a meta-analysis. Ophthalmology 112:1599–1607CrossRefPubMed
32.
Zurück zum Zitat Li W, Judge H, Gragoudas ES, Seddon JM, Egan KM (2000) Patterns of tumor initiation in choroidal melanoma. Cancer Res 60(14):3757–3760PubMed Li W, Judge H, Gragoudas ES, Seddon JM, Egan KM (2000) Patterns of tumor initiation in choroidal melanoma. Cancer Res 60(14):3757–3760PubMed
33.
Zurück zum Zitat Lutz JM, Cree I, Sabroe S et al (2005) Occupational risks for uveal melanoma results from a case-control study in nine European countries. Cancer Causes Control 16:437–447CrossRefPubMed Lutz JM, Cree I, Sabroe S et al (2005) Occupational risks for uveal melanoma results from a case-control study in nine European countries. Cancer Causes Control 16:437–447CrossRefPubMed
Metadaten
Titel
Hormonal exposures and the risk of uveal melanoma
verfasst von
Thomas Behrens
Linda Kaerlev
Ian Cree
Jean-Michel Lutz
Noemia Afonso
Mikael Eriksson
Pascal Guénel
Franco Merletti
Maria Morales-Suarez-Varela
Aivars Stengrevics
Svend Sabroe
Diane Cyr
Agustin Llopis-González
Giuseppe Gorini
Galina Sharkova
Lennart Hardell
Wolfgang Ahrens
Publikationsdatum
01.10.2010
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 10/2010
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-010-9591-9

Weitere Artikel der Ausgabe 10/2010

Cancer Causes & Control 10/2010 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.